Mekanisme resistensi antibiotik pada pengobatan Gonore

Miranda Ashar

Abstract


Gonore merupakan salah satu penyakit infeksi menular seksual disebabkan oleh kuman Neisseria gonorrhoeae. Penyakit dapat menimbulkan komplikasi berupa pelvic inflammatory disease pada perempuan atau epididimitis pada laki–laki yang dapat menyebabkan infertilitas. Gonore dapat disembuhkan dengan menggunakan antibiotik. Namun, saat ini terdapat prevalensi tinggi dari strain Neisseria gonorrhoeae yang resistensi terhadap sebagian besar antibiotik seperti penisilin, sefalosporin, makrolida, dan fluorokuinolon. Oleh karena itu, mekanisme resistensi antibiotik pada pengobatan gonore dan data resistensi lokal harus diketahui, sehingga pengobatan yang diberikan kepada pasien dapat efektif dan mencegah terjadinya komplikasi.

References


World Health Organization. Global Incidence and Prevalence of Selected Curable Sexually Transmitted Infections-2008.2012.15-20.

Bignell C, Unemo M. European Guideline on The Diagnosis and Treatment of Gonorrhoea in Adults-2012. International Journal STD AIDS.2013 Feb;24:85-92.

World Health Organization. Report on Global Sexually Transmitted Infection Surveillance.2018.33-37.

Cole MJ, Spiteri G, Chisholm SA, Hoffmann S, Ison CA, et al. Emerging Cephalosporin and Multidrug-Resistant Gonorrhoea in Europe. Europe's Journal on Infection Disease Surveillance, Epidemiology, Prevention and Control.2014 Nov 13;19(45):45-55.

Hananta IP, Dam AP, Bruisten SM, Loeff MF, Soebono H, Christiaan HJ. Gonorrhea in Indonesia: High Prevalence of Asymptomatic Urogenital but No Circulating Extended Spectrum Cephalosporin-Resistant Neisseria gonorrhoeae Strains in Jakarta, Yogyakarta, and Denpasar, Indonesia. Sexually Transmited disease.2016 Oct;43(10): 608-616.

Indriatmi W, Prayogo RL, Nilasari H, Suseno LS. Antimicrobial Resistence of Neisseria gonorrhoeae in Jakarta, Indonesia: A Cross-Sectional Study. Sexual Health Journal.2019 Dec 16:15-20.

Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance 2015.2016.11-20.

Rizal Y. Hubungan Perilaku Cara Mendapatkan Pengobatan Pada Penderita Uretritis Gonore Akuta Non Komplikata Pria Terhadap Resistensi Obat. Padang: Fakultas Kedokteran Universitas Andalas;2011.

Tapsall JW, Ndowa F, Lewis DA, Unemo M. Meeting The Public Health Challenge of Multidrug-and Extensively Drug-Resistant Neisseria gonorrhoeae. Expert Review Anti. Infectious Theraphy. 2009 Sep;7(7):821–834.

World Health Organization. WHO Guidelines for The Treatment of Neisseria gonorrhoeae.2016.17-19.

Kementerian Kesehatan Republik Indonesia. Pedoman Nasional Penanganan Infeksi Menular Seksual 2011. 2011.24-25,39-40.

Unemo M, Shafer WM. Antibiotic Resistance in Neisseria gonorrhoeae: Origin, Evolution, and Lessons Learned for The Future. Annals of The New York Academy Science.2011 Aug;1230:1928.

Lindsay CS, Sean M, Rita OP. Gonorrhea, Mycoplasma and Vaginosis. In: Kang S, Amagai M, Bruckner anna l, Erik AH, David J margolis, Michael AJM, et al., editors. Fitzpatricks dermatology in general medicine. 9th ed. New York: McGraw-Hill;2019.3207- 3212.

Munita JM, Arias CA. Mechanisms Antibiotic Resistance. Microbial Spectrum.2016 Apr;4(2).

Reygaert WC. An Overview of Antimicrobial Resistance Mechanisms of Bacteria. Microbiology Journal. 2018 June;4(3):482-501.

Day MJ, Spiteri G, Jacobsson S, Woodfoord N, Gauci AJ, et al. Stably High Azithromycin Resistance and Decreasing Ceftriaxone Susceptibility in Neisseria gonorrhoeae in 25 European Countries, 2016. BMC Infectious Diseases.2018;18:609.

Unemo M, Lahra MM, Cole M, Galarza P, Ndowa F, et al. World Health Organization Global Gonococcal Antimicrobial Surveillance Program (WHO GASP): Review of New Data and Evidence to Inform International Collaborative Actions and Research Efforts. Sex Health 2019 Sep;16(5):412-425.

Workowski KA, Bolan GA, U.S. Sexually Transmitted Diseases Treatment Guidelines, 2015. Centers for Disease Control and Prevention.2015; 64:1–137.

Ana PR, Kesia TB, Beatriz MM, Sergio EL. Antimicrobial Resistance in Neisseria gonorrhoeae: History, Molecular Mechanism and Epidemiological Aspects of An Emerging Global Threat. Brazilian Journal of Microbiology.2017 Jul 7;267:1-12.

Lewis DA. 2010. The Gonococcus Fights Back: Is This Time A Knock Out?. Sexual Transmited Infection.2010 Nov;86(6):415– 421.

Unemo M, Golparian D, Skogen V, Olsen AO, Moi H, Syversen G, et al. Neisseria gonorrhoeae Strain With High-Level Resistance to Spectinomycin Due to A Novel Resistance Mechanism (Mutated Ribosomal Protein S5) Verified in Norway. Antimicrobial Agents Chemotherapy.2012 Nov 26;57(2):1057–1061.

Yasuda M, Hatazaki K, Ito S, Kitanohara M, Yoh M, et al. Antimicrobial Susceptibility of Neisseria gonorrhoeae in Japan from 2000 to 2015. Sexually Transmitted Diseases.2017;44:149-53.

Vereshchagin VA, Ilina EN, Malakhova MV, Zubkov MM, Sidorenko SV, et al. Fluoroquinolone-resistant Neisseria gonorrhoeae isolates from Russia: Molecular Mechanisms Implicated. Journal of Antimicrobial Chemotherapy.2004;53:653-656.

Belkacem A, Jacquier H, Goubard A, Mougari F, Ruche GL, Patey O, et al. Molecular Epidemiology and Mechanisms of Resistance of Azithromycin-Resistant Neisseria gonorrhoeae Isolated in France During 2013–2014. Journal Antimicrobial Chemotheraphy.2016 Sep;71(9):2471–2478.

Allen VG, Seah C, Martin I, Melano RG. Azithromycin Resistance Is Coevolving With Reduced Susceptibility to Cephalosporins in Neisseria gonorrhoeae in Ontario, Canada. Antimicrobial Agents Chemotherapy.2014;58(5):2528–2534.

Stevens K, Zaia A, Tawil S, Bates J, Hicks V, Whiley D, et al. Neisseria gonorrhoeae Isolates With High-Level Resistance to Azithromycin in Australia. Journal Antimicrobial Chemotherapy.2015 Apr;70(4):1267–1268.

Unemo M, Golparian D, Nicholas R, Ohnishi M. High-Level Cefixime- and Ceftriaxone-Resistant N. gonorrhoeae in France: Novel penA Mosaic Allele in A Successful International Clone Causes Treatment Failure. Antimicrobial Agents Chemotherapy.2012;56:1273–1280.

Tomberg J, Unemo M, Davies C, Nicholas RA. Molecular and Structural Analysis of Mosaic Variants of Penicillin-Binding Protein 2 Conferring Decreased Susceptibility to Expanded-Spectrum Cephalosporins in Neisseria gonorrhoeae: Role of Epistatic Mutations. Biochemistry.2010;49:8062–8070.

Galimand M, Gerbaud G, Courvalin P. Spectinomycin Resistance in Neisseria spp. Due to Mutations in 16S rRNA. Antimicrobial Agents Chemotherapy.2010;44(5):1365–1366.


Full Text: PDF

DOI: 10.24815/jks.v22i1.20819

Refbacks

  • There are currently no refbacks.